Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Rheumatologists Explore Connection Between Tooth Loss and Rheumatoid Arthritis

Staff  |  Issue: November 2013  |  November 1, 2013

Foundation News

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

 

Groundbreaking research into the possible links between the bacteria that lead to gum disease and the risk of developing rheumatoid arthritis (RA) is fueled by support from the Rheumatology Research Foundation, says rheumatologist Ted Mikuls, MD, associate professor of internal medicine at the University of Nebraska in Omaha.

Developing periodontitis, or gum disease that can lead to tooth loss, may somehow be connected to both RA disease severity and a person’s risk for developing RA in the first place, says Dr. Mikuls. “In people with RA, we see higher rates of tooth loss and gum disease, but that’s looking at people after they’ve been diagnosed,” he says. With a grant from the Foundation, Dr. Mikuls and his colleagues are looking closer to find very early signs of RA risk well before diagnosis or even symptomatic disease starts. “There is a recent resurgence of interest in the main bacteria that lead to gum disease, and how they may be creating molecules in the mouth, or changing the proteins in the mouth, and how this may drive the autoantibodies that we see in RA.” Dr. Mikuls’ aim is to better establish those links with a Foundation-supported project grant that was awarded in 2010, part of the Foundation’s Disease Targeted Research Initiative.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Mikuls (right) and his colleagues are using a grant from the Rheumatology Research Foundation to investigate the link between tooth decay and RA.

One paper already published in Arthritis & Rheumatism in 2012 looked into the links between the bacterium Porphyromonas gingivalis and autoantibodies related to RA in people who were at higher risk for developing RA, including those with close relatives diagnosed with the disease. The early study concluded that infection with this bacterium may play a central role in the early loss of tolerance to autoantibodies like ACPA or rheumatoid factor that occurs in the pathogenesis of RA. Periodontists and rheumatologists are working together on this ongoing research, Dr. Mikuls notes.

Periodontitis is a common condition in the general public, but Dr. Mikuls stresses that this project is just one early step towards understanding its possible role in chronic disease risk. “It’s probably not the cause of all RA, but in some patients could serve as a trigger,” he says. Preventive measures, like maintaining frequency of dental visits for cleanings and good oral health practices, may even play a role in reducing RA risk or symptoms, he notes.

Page: 1 2 | Single Page
Share: 

Filed under:From the CollegeResearch Rheum Tagged with:Rheumatoid arthritisRheumatology Research Foundation

Related Articles

    Importance of Oral Health, Mouth-Body Connection to Rheumatic Diseases Highlighted

    August 10, 2016

    Look inside the oral cavity of a patient for answers that go beyond what we perceive as the dentist’s domain. So goes the thinking of medical professionals interested in how oral health and bacteria-driven disease, such as periodontitis, may be linked to rheumatic disease, especially rheumatoid arthritis (RA). Bad bacteria that live in the mouth…

    BlurryMe / shutterstock.com

    The Prevention & Management of Medication-Related Osteonecrosis of the Jaw

    March 15, 2021

    Medication-related osteonecrosis of the jaw (MRONJ) is a con­dition that manifests as exposed, necrotic and non-healing jaw bone in patients who have been treated with bisphosphonates, denosumab, chemotherapeutic agents, anti-angiogenic drugs, tyrosine kinase inhibitors, thalidomide and steroids.1-4 These medications are admin­istered via intravenous, subcutaneous and oral routes to manage osteopenia; osteoporosis; hypercalcemia of malignancy; bone…

    2013 ACR/ARHP Annual Meeting: Researchers Explore Role of Pathogens, Quality of Care in Rheumatoid Arthritis

    January 1, 2014

    Funding by the Rheumatology Research Foundation has furthered studies on the impact of infectious agents and autoantigens, periodontal disease, and disease-modifying antirheumatic drugs on patients with RA

    New Study: Does Urate-Lowering Therapy Reduce Gout-Patient Mortality?

    New Study: Does Urate-Lowering Therapy Reduce Gout-Patient Mortality?

    March 18, 2019

    Results of a recent study in Arthritis & Rheumatology fail to clarify whether urate-lowering therapies may potentially reduce mortality risk in patients with gout.1 The study also underscores the fact that many physicians are not following the ACR guideline to help their patients achieve target serum urate levels. Partly because of this, it remains unclear…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences